by Maria Zannes | Feb 21, 2024 | Press Releases
SAN ANTONIO, Texas (Feb. 21, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, provides a summary of recent Company news. Lung...
by Maria Zannes | Feb 6, 2024 | Press Releases
Medical Director of Pennsylvania’s Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice SAN ANTONIO,...
by Maria Zannes | Jan 30, 2024 | Press Releases
SAN ANTONIO, Texas (Jan. 30, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, provides a summary of recent Company news. Precision...
by Maria Zannes | Jan 23, 2024 | Press Releases
Indian Patent Office Grants Patent Related to Porphyrin Compounds for Targeted Cancer Treatment SAN ANTONIO, Texas (Jan. 23, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for...
by Maria Zannes | Jan 8, 2024 | Press Releases
SAN ANTONIO, Texas (Jan. 8, 2024) – Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease....
by Maria Zannes | Dec 5, 2023 | Press Releases
SAN ANTONIO, Texas (Dec. 5, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie Platt,...
